Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy in iNPH Shunting (PENS) Trial

NCT: NCT05081128 · ACTIVE_NOT_RECRUITING

NCT IDNCT05081128
StatusACTIVE_NOT_RECRUITING
Start Date2022-05-18
Completion2027-08

Brief Summary

The Placebo-Controlled Efficacy in Idiopathic Normal Pressure Hydrocephalus (iNPH) Shunting (PENS) trial is a multi-center blinded, randomized, placebo-controlled design investigation of cerebrospinal fluid (CSF) shunt surgery to study the shunt efficacy in iNPH patients.

Frequently Asked Questions

What is Efficacy in iNPH Shunting (PENS) Trial?

Efficacy in iNPH Shunting (PENS) Trial is a clinical trial registered under NCT05081128. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05081128?

The current status of NCT05081128 (Efficacy in iNPH Shunting (PENS) Trial) is: ACTIVE_NOT_RECRUITING.

When did Efficacy in iNPH Shunting (PENS) Trial start?

Efficacy in iNPH Shunting (PENS) Trial started on 2022-05-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑